Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
8.7 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Pharmacy; practice, regulation by Board of Pharmacy, report. | Practice of pharmacy; regulation by Board of Pharmacy;report. Provides that compounding of drugs provided to the Department ofCorrections for the purpose of carrying out an execution by lethal injectionshall constitute the practice of pharmacy and be subject to the requirements ofthe Drug Control Act and the jurisdiction of the Board of Pharmacy. The billprovides that only outsourcing facilities may compound such drugs; currently,both pharmacies and outsourcing facilities may compound such drugs. The billalso clarifies that the Board of Pharmacy may inspect any pharmacy or otherplace where drugs, cosmetics, or devices are manufactured, stored, or dispensedin response to complaints received by the Board, in any case in which the Boardhas reason to believe that the pharmacy or such other place has violated anystate or federal law or as otherwise deemed necessary by the Board to protectthe health and safety of the public. The bill amends the membership of theBoard of Health to include a pharmacist with experience in compounding,requires the Board of Health to educate the public about safe use of compoundeddrugs, and requires the Board of Health and the Board of Pharmacy to report annuallyto the Governor and the General Assembly on actions taken to (i) ensure thesafety and quality of compounded drugs produced by compounding pharmacies andoutsourcing facilities located in the Commonwealth and compounding pharmaciesand outsourcing facilities located outside the Commonwealth that providecompounded drugs to patients in the Commonwealth; (ii) reduce illegal use ofopioids and opioid abuse in the Commonwealth; and (iii) implement provisions ofand ensure compliance with the requirements of Title II of the federal DrugSupply Chain Security Act of 2013 related to prescription drug identification,tracing, and verification. | us/states/va | Virginia General Assembly | 2020 | SB 270 | Virginia SB 270 (2020) |
|
enacted |
|
4 | 39 | 9 | 2020-01-03 | 2020-04-11 | openstates | ocd-bill/594ec9b4-4c2a-429f-9d95-4ce6c1d417de | https://lis.virginia.gov/cgi-bin/legp604.exe?201+sum+SB270 | c77f81d1006a378c1f94eb69ca4230ea32311d32151594471371c667de082410 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 270 (2020) — Pharmacy; practice, regulation by Board of Pharmacy, report.
Practice of pharmacy; regulation by Board of Pharmacy;report. Provides that compounding of drugs provided to the Department ofCorrections for the purpose of carrying out an execution by lethal injectionshall constitute the practice of pharmacy and be subject to the requirements ofthe Drug Control Act and the jurisdiction of the Board of Pharmacy. The billprovides that only outsourcing facilities may compound such drugs; currently,both pharmacies and outsourcing facilities may compound such drugs. The billalso clarifies that the Board of Pharmacy may inspect any pharmacy or otherplace where drugs, cosmetics, or devices are manufactured, stored, or dispensedin response to complaints received by the Board, in any case in which the Boardhas reason to believe that the pharmacy or such other place has violated anystate or federal law or as otherwise deemed necessary by the Board to protectthe health and safety of the public. The bill amends the membership of theBoard of Health to include a pharmacist with experience in compounding,requires the Board of Health to educate the public about safe use of compoundeddrugs, and requires the Board of Health and the Board of Pharmacy to report annuallyto the Governor and the General Assembly on actions taken to (i) ensure thesafety and quality of compounded drugs produced by compounding pharmacies andoutsourcing facilities located in the Commonwealth and compounding pharmaciesand outsourcing facilities located outside the Commonwealth that providecompounded drugs to patients in the Commonwealth; (ii) reduce illegal use ofopioids and opioid abuse in the Commonwealth; and (iii) implement provisions ofand ensure compliance with the requirements of Title II of the federal DrugSupply Chain Security Act of 2013 related to prescription drug identification,tracing, and verification.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Acts of Assembly Chapter text (CHAP1166) (committee substitute) — source
- Bill text as passed Senate and House (SB270ER) (committee substitute) — source
- Engrossed by Senate - committee substitute SB270S1 (committee substitute) — source
- Impact statement from DPB (SB270) (committee substitute) — source
Votes
- Constitutional reading dispensed (37-Y 0-N) — 37–0 (pass) · upper
- Reported from Health, Welfare and Institutions (13-Y 9-N) — 13–9 (pass) · lower
- VOTE: Passage (53-Y 45-N) — 52–45 (pass) · lower
- Read third time and passed Senate (22-Y 18-N) — 22–18 (pass) · upper
- House amendments agreed to by Senate (22-Y 17-N) — 22–17 (pass) · upper
- Reported from Education and Health with substitute (11-Y 3-N 1-A) — 11–3 (pass) · upper
- Reconsideration of passage agreed to by Senate (40-Y 0-N) — 40–0 (pass) · upper
- Subcommittee recommends reporting (4-Y 2-N) — 4–2 (pass) · lower
- Passed Senate (21-Y 19-N) — 21–19 (pass) · upper
Sponsors
- John J. Bell — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2020-01-03 Prefiled and ordered printed; offered 01/08/20 20102391D
introduction - 2020-01-03 Referred to Committee on Education and Health
referral-committee - 2020-01-16 Assigned Education sub: Health Professions
referral-committee - 2020-01-22 Impact statement from DPB (SB270)
- 2020-01-30 Reported from Education and Health with substitute (11-Y 3-N 1-A)
committee-passage - 2020-01-30 Committee substitute printed 20106582D-S1
substitution - 2020-01-31 Constitutional reading dispensed (37-Y 0-N)
- 2020-02-03 Read second time
reading-2 - 2020-02-03 Reading of substitute waived
- 2020-02-03 Committee substitute agreed to 20106582D-S1
- 2020-02-03 Engrossed by Senate - committee substitute SB270S1
- 2020-02-03 Impact statement from DPB (SB270S1)
- 2020-02-04 Read third time and passed Senate (22-Y 18-N)
passage, reading-3 - 2020-02-04 Reconsideration of passage agreed to by Senate (40-Y 0-N)
- 2020-02-04 Passed Senate (21-Y 19-N)
passage - 2020-02-13 Placed on Calendar
- 2020-02-13 Read first time
reading-1 - 2020-02-13 Referred to Committee on Health, Welfare and Institutions
referral-committee - 2020-02-16 Assigned HWI sub: Health Professions
referral-committee - 2020-02-21 Subcommittee recommends reporting (4-Y 2-N)
- 2020-02-25 Reported from Health, Welfare and Institutions (13-Y 9-N)
committee-passage - 2020-02-27 Read second time
reading-2 - 2020-02-28 Passed by for the day
- 2020-03-02 Passed by for the day
- 2020-03-03 Read third time
reading-3 - 2020-03-03 Passed by temporarily
- 2020-03-03 House committee, floor amendments and substitutes offered
- 2020-03-03 Amendments by Delegate Delaney agreed to
amendment-passage - 2020-03-03 Engrossed by House as amended
- 2020-03-03 Passed House with amendments (53-Y 45-N)
passage - 2020-03-03 VOTE: Passage (53-Y 45-N)
- 2020-03-04 House amendments agreed to by Senate (22-Y 17-N)
- 2020-03-07 Enrolled
- 2020-03-07 Signed by President
- 2020-03-08 Signed by Speaker
- 2020-03-09 Impact statement from DPB (SB270ER)
- 2020-03-12 Enrolled Bill Communicated to Governor on March 12, 2020
- 2020-03-12 Governor's Action Deadline 11:59 p.m., April 11, 2020
- 2020-04-11 Approved by Governor-Chapter 1166 (effective 7/1/20)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/594ec9b4-4c2a-429f-9d95-4ce6c1d417de. Confidence: reported (aggregated from official Virginia legislature records).